Clinical Trial Participation

Clinical Trial Participation

Clinical trials are an important step in discovering the causes, treatments and ultimately a cure for Parkinson’s. Before drugs can be approved to be used in a patient population they are rigorously reviewed through the mechanism of a clinical trial.

APDA is pleased to maintain this area for your convenient access to basic information on research studies on-going at various movement disorder centers across the country. Although APDA has not individually reviewed or specifically endorsed each study posted here, each has been reviewed and approved by the Institutional Review Board at its respective medical center.

For further information on any study posted here, please utilize the specific contact information provided with the description of the actual study in which you are interested. As always, consult your physician to discuss the individual benefits and risks of each study prior to participating.

To increase your awareness and connect you with ongoing research and clinical trials visit:

  • ClinicalTrials.gov
  • Foxtrialfinder.com
  • Parkinson-Study-Group.org
  • NIH Clinical Trial Finder
  • Sage Therapeutics sponsored trial for Parkinson’s Disease Mild Cognitive Impairment (PD-MCI): Research study for adults ages 50 to 75 years old who have been diagnosed with PD-MCI. The purpose of this study is to evaluate the safety and tolerability of an investigational medication. Participants must have a confirmed diagnosis of PD-MCI and have a study partner who is reliable, competent, at least 18 years of age, and willing to be available to the study center by phone.  The study is currently enrolling at the following sites:
    • Long Beach, CA – Collaborative Neuroscience Network – Long Beach
    • Fort Myers, FL – Neuropsychiatric Research Center of Southwest Florida
    • Port Charlotte, FL – Parkinson’s Disease Treatment Center of Southwest Florida
    • West Palm Beach, FL – Palm Beach Neurology and Premiere Research Institute

    For additional information on the PARADIGM STUDY, please visit the trial listing on clinicaltrials.gov or contact clinicaltrialsinquiry@sagerx.com.

  • APDA-sponsored trial for Telehealth Treatment for Depression in Parkinson’s DiseaseResearch study investigating the effect of telehealth treatment for depression in individuals with Parkinson’s disease. The treatment (cognitive behavioral therapy) may reduce depression and increase quality of life. Participants will receive treatment at no cost in the comfort of their own home, over secure videoconference. Participants must have a diagnosis of Parkinson’s disease and be currently experiencing symptoms of depression. For more information, please contact the Vision & Cognition Laboratory at 617-353-6476.
  • NIH study #17-N-0076 Parkinson’s Disease Research Study in Bethesda, MD: The National Institutes of Health (NIH) in Bethesda, Maryland seeks volunteers with Parkinson’s disease to be part of a clinical research study about whether N-Acetylcysteine (NAC) has a particular effect on brain chemistry in patients with Parkinson’s disease. Researchers are evaluating whether NAC can protect the nerve cells in the brain that control movement. For more information: Call: 1-800-411-1222 (TTY 1-866-411-1010)

WEBINAR: Parkinson’s Disease Spotlight On Clinical Trials

Here is an overview of the APDA webinar on Parkinson’s clinical trials, hosted on 2.9.16, including why clinical trials are vital to Parkinson’s research and how to participate.

Watch Webinar

Learn more about Clinical Trials

Progress in treating Parkinson’s disease (PD) depends on clinical trials, and the success of clinical trials depends on people like you who volunteer to enroll in a trial. Download our brochure to learn about clinical trials, what they can offer you, and how you can learn more.

Download Now